Intellectual Property
Patent Infringement
Omeprazole Formulation Patents
Astrazeneca Ab, et al. v. Apotex Corporation, et al.
Published: Dec. 21, 2013 | Result Date: Dec. 3, 2013 | Filing Date: Jan. 1, 1900 |Case number: 1:01-cv-09351-DLC Bench Decision – $76,022,000
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Already a subscriber?
Sign In